Pulmonary carcinoids (PCs) display the common features of all well-differentiated neuroendocrine neoplasms (NEN) and are classified as low- and intermediate-grade malignant tumours (i.e., typical and atypical carcinoid, respectively). There is a paucity of randomised studies dedicated to advanced PCs and management principles are drawn from the larger gastroenteropancreatic NEN experience. There is growing evidence that NEN anatomic subgroups have different biology and different responses to treatment and, therefore, should be investigated as separate entities in clinical trials. In this review, we discuss the existing evidence and limitations of tumour classification, diagnostics and staging, prognostication, and treatment in the setting o...
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision...
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision...
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision...
Pulmonary carcinoids (PCs) display the common features of all well-differentiated neuroendocrine neo...
Pulmonary carcinoids (PCs) display the common features of all well-differentiated neuroendocrine neo...
Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized studies, this expert...
Background: Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized studies,...
Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized studies, this expert...
Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized studies, this expert...
BACKGROUND Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized studie...
The current classification of pulmonary neuroendocrine tumours includes four subtypes: low-grade typ...
Neuroendocrine neoplasms of the lung represent about 20% to 30% of all neuroendocrine tumors. On the...
The current classification of pulmonary neuroendocrine tumours includes four subtypes: low-grade typ...
An estimated 20% to 30% of all neuroendocrine tumours originate in the bronchial tree and lungs. Acc...
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision...
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision...
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision...
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision...
Pulmonary carcinoids (PCs) display the common features of all well-differentiated neuroendocrine neo...
Pulmonary carcinoids (PCs) display the common features of all well-differentiated neuroendocrine neo...
Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized studies, this expert...
Background: Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized studies,...
Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized studies, this expert...
Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized studies, this expert...
BACKGROUND Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized studie...
The current classification of pulmonary neuroendocrine tumours includes four subtypes: low-grade typ...
Neuroendocrine neoplasms of the lung represent about 20% to 30% of all neuroendocrine tumors. On the...
The current classification of pulmonary neuroendocrine tumours includes four subtypes: low-grade typ...
An estimated 20% to 30% of all neuroendocrine tumours originate in the bronchial tree and lungs. Acc...
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision...
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision...
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision...
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision...